产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 97% | 询价 | |||
| 100mg | 97% | 询价 | |||
| 250mg | 97% | 询价 | |||
| 1g | 97% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 97% | 询价 | |||
| 100mg | 97% | 询价 | |||
| 250mg | 97% | 询价 | |||
| 1g | 97% | 询价 |
CAS No. |
171596-42-2 |
|---|---|
中文名称 |
(1S,3R)-甲基 1-(苯并[d][1,3]二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-甲酸酯 |
英文名称 |
(1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
别名 |
(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester;Tadalafil Impuirty Ⅵ;Tadalafil impurity 18/Methyl (1S,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate;Tadalafil-016-1S3R;Tadanafil impurities 7;Tadalafil Related Impuirty 7;1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-, methyl ester, (1S,3R)-;Tadalafil intermediate I diastereomer 1 |
标准英文名 |
methyl (1S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
分子式 |
C20H18N2O4 |
分子量 |
350.37 |
精确分子量 |
350.13 |
SMILES |
O=C([C@H]1CC2=C([C@H](C3=CC=C(OCO4)C4=C3)N1)NC5=C2C=CC=C5)OC |
标准SMILES |
COC(=O)[C@H]1CC2C3C=CC=CC=3NC=2[C@@H](N1)C1=CC=C2OCOC2=C1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
LIPVUDSNGRJSQE-QAPCUYQASA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Keep in dark place, Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|